Folate Receptor-Beta Has Limited Value for Fluorescent Imaging in Ovarian, Breast and Colorectal Cancer.

Autor: Esther de Boer, Lucia M A Crane, Marleen van Oosten, Bert van der Vegt, Tineke van der Sluis, Paulien Kooijman, Philip S Low, Ate G J van der Zee, Henriette J G Arts, Gooitzen M van Dam, Joost Bart

Publikováno v: PLoS ONE, Vol 10, Iss 8, p e0135012 (2015)

Tumor-specific targeted imaging is rapidly evolving in cancer diagnosis. The folate receptor alpha (FR-α) has already been identified as a suitable target for cancer therapy and imaging. FR-α is present on ~40% of human cancers. FR-β is known to b

Externí odkaz: https://doaj.org/article/8ee93fb047004a198179bddc54e38405

Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer

Autor: J. H. Schagen van Leeuwen, Simone N. Koole, M A P C van Ham, Arend G. J. Aalbers, Ralph H. Hermans, W.J. van Driel, Gabe S. Sonke, I.H.J.T. de Hingh, Victor J. Verwaal, Karolina Sikorska, J. van der Velden, Henk W.R. Schreuder, Jacobien M. Kieffer, Neil K. Aaronson, K.K. Van de Vijver, Henriette J. G. Arts

Publikováno v: European Journal of Surgical Oncology, 47, 101-107
European Journal of Surgical Oncology, 47, 1, pp. 101-107
Koole, S N, Kieffer, J M, K.Sikorska, Schagen van Leeuwen, J H, Schreuder, H W R, Hermans, R H, de Hingh, I H, van der Velden, J, Arts, H J, van Ham, M A P C, Aalbers, A G, Verwaal, V J, Van de Vijver, K K, Sonke, G S, van Driel, W J & Aaronson, N K 2021, ' Health-related quality of life after interval cytoreductive surgery with or without hyperthermic intraperitoneal chemotherapy (HIPEC) in patients with stage III ovarian cancer ', European Journal of Surgical Oncology, vol. 47, no. 1, pp. 101-107 . https://doi.org/10.1016/j.ejso.2019.05.006

Introduction The addition of hyperthermic intraperitoneal chemotherapy (HIPEC) to interval cytoreductive surgery (CRS) improves recurrence-free (RFS) and overall survival (OS) in patients with FIGO stage III ovarian cancer. We evaluated the effect of

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::a663b5dfcc3947bddfc209fc18114c8b
https://hdl.handle.net/11370/87f6cf02-6a98-4685-989e-d4ce2a3aa0a5

Reduced morbidity by using LigaSure compared to conventional inguinofemoral lymphadenectomy in vulvar cancer patients: A randomized controlled trial

Autor: Henriette J. G. Arts, Corine M. Koopmans, Anne-Floor W. Pouwer, Johanna M.A. Pijnenborg, Joanna IntHout, Joanne A. de Hullu

Publikováno v: Surgical Oncology-Oxford, 35, pp. 149-155
Surgical Oncology-Oxford, 35, 149-155
Surgical oncology-Oxford, 35, 149-155. ELSEVIER SCI LTD

Background: Inguinofemoral lymphadenectomy (IFL) is part of the surgical treatment of different malignancies of the genital tract and/or the lower limb including vulvar carcinoma, penile carcinoma and melanoma. IFL is associated with morbidity in up

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::c21b53039e0f449010ba3f0ac8e5f0b6
https://pubmed.ncbi.nlm.nih.gov/32877884

Laparoscopy to Predict the Result of Primary Cytoreductive Surgery in Patients With Advanced Ovarian Cancer: A Randomized Controlled Trial

Autor: Brent C. Opmeer, Katja N. Gaarenstroom, Mirjam J. A. Engelen, M. Caroline Vos, Christiana A. Naaktgeboren, Kees G. Gerestein, Patrick M.M. Bossuyt, Ben W.J. Mol, Anje M. Spijkerboer, Guus Fons, Toon Van Gorp, Petra L.M. Zusterzeel, Henk W.R. Schreuder, Hannah S. van Meurs, Eltjo M.J. Schutter, Roelien van de Vrie, Henk G. ter Brugge, Gemma G. Kenter, Maarten van Haaften, Ward Hofhuis, Erik A. Boss, Marrije R. Buist, Johanna M.A. Pijnenborg, Henriette J. G. Arts, Marianne J. Rutten

Publikováno v: Journal of Clinical Oncology, 35(6), 613-621. AMER SOC CLINICAL ONCOLOGY
Journal of Clinical Oncology, 35(6), 613. American Society of Clinical Oncology
Journal of clinical oncology, 35(6):6, 613-621. American Society of Clinical Oncology
Journal of Clinical Oncology, 35, 6, pp. 613-621
Journal of Clinical Oncology, 35(6), 613
Journal of Clinical Oncology, 35, 613-621
Journal of Clinical Oncology, 35(6), 613-621. American Society of Clinical Oncology

Purpose To investigate whether initial diagnostic laparoscopy can prevent futile primary cytoreductive surgery (PCS) by identifying patients with advanced-stage ovarian cancer in whom > 1 cm of residual disease will be left after PCS. Patients and Me

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::88afffec900de1bc3a3271a3325055c3
https://doi.org/10.1200/jco.2016.69.2962

Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial

Autor: Valesca P. Retèl, Willemien J. van Driel, Arend G. J. Aalbers, Jacobien M. Kieffer, Ralph H. Hermans, Jules H. Schagen van Leeuwen, Christiaan van Lieshout, Evi van Schagen, Ignace H J T de Hingh, Wim H. van Harten, Koen Van de Vijver, Jacobus van der Velden, Harm van Tinteren, Simone N. Koole, Gabe S. Sonke, Victor J. Verwaal, Karolina Sikorska, Neil K. Aaronson, Henriette J. G. Arts, Leon F.A.G. Massuger, Henk W.R. Schreuder

Publikováno v: Koole, S N, van Lieshout, C, van Driel, W J, van Schagen, E, Sikorska, K, Kieffer, J M, Schagen van Leeuwen, J H, Schreuder, H W R, Hermans, R H, de Hingh, I H, van der Velden, J, Arts, H J, Massuger, L F A G, Aalbers, A G, Verwaal, V J, Van de Vijver, K K, Aaronson, N K, van Tinteren, H, Sonke, G S, van Harten, W H & Retèl, V P 2019, ' Cost Effectiveness of Interval Cytoreductive Surgery With Hyperthermic Intraperitoneal Chemotherapy in Stage III Ovarian Cancer on the Basis of a Randomized Phase III Trial ', Journal of clinical oncology : official journal of the American Society of Clinical Oncology, vol. 37, no. 23, pp. 2041-2050 . https://doi.org/10.1200/JCO.19.00594
Journal of Clinical Oncology, 37, 23, pp. 2041
Journal of clinical oncology : official journal of the American Society of Clinical Oncology, 37(23), 2041. American Society of Clinical Oncology
Journal of clinical oncology, 37(23), 2041-2050. American Society of Clinical Oncology
Journal of Clinical Oncology, 37, 2041
Journal of Clinical Oncology, 37(23), 2041-2050. American Society of Clinical Oncology
Journal of Clinical Oncology, 37(23), 2041-2050. AMER SOC CLINICAL ONCOLOGY
Obstetrical and Gynecological Survey, 74(10), 592-593. Lippincot, Williams & Wilkins
Obstetrical and Gynecological Survey, 74(10), 592-593. Lippincott Williams and Wilkins

Despite advancements in treatment modalities, the 10-year survival rate of women diagnosed with advanced-stage ovarian cancer has remained between 10% and 15% for the past 20 years. This is in part due to the majority of cases being diagnosed when di

Externí odkaz: https://explore.openaire.eu/search/publication?articleId=doi_dedup___::77a8bad7b26f8ceabbbeb19b8f608203
https://pure.au.dk/portal/da/publications/cost-effectiveness-of-interval-cytoreductive-surgery-with-hyperthermic-intraperitoneal-chemotherapy-in-stage-iii-ovarian-cancer-on-the-basis-of-a-randomized-phase-iii-trial(b14e639e-4ce3-4f8a-adfa-a6034c3ed0df).html